TRIB TRINITY BIOTECH PLC

BEARISH Impact: 6/10 6-K
Horizon weeks Filed Jun 12, 2026 Processed 2d 14h ago SEC 0001554855-26-001322
Notable filing: 6-K

Price Chart

Loading chart...

Executive Summary

Trinity Biotech filed a 6-K on June 12, 2026, announcing a new at-the-market (ATM) offering agreement with Lucid Capital Markets for up to $4.35 million of ADSs, replacing a terminated Craig-Hallum ATM. This marks the company's third distinct equity-linked capital raise in 2026 (following the Yorkville SEPA and prior ATM), underscoring acute liquidity pressure given the deeply negative equity position (-$72M shareholders' equity) and heavy debt load ($132M total debt) reported in the most recent 20-F. The filing is bearish — the constant need for new ATM facilities signals a structural inability to fund operations organically, and incremental dilution compounds existing overhang from convertible obligations.

Actionable Insight

Monitor drawdown pace on the Lucid ATM — aggressive daily sales would signal imminent cash burn. The company's multi-pronged equity reliance (SEPA + ATM + ATM) suggests continued stock overhang; any bounce is likely a selling opportunity into the ATM. Watch for Nasdaq delisting updates (MVPHS non-compliance) and next quarterly filing for cash runway disclosure.

Key Facts

  • New ATM agreement with Lucid Capital Markets for up to $4,352,314 in ADSs, filed same day as this 6-K.
  • Prior Craig-Hallum ATM terminated June 2, 2026; had been inactive since March 2025.
  • Third equity-linked capital vehicle established in 2026 (Yorkville SEPA, prior ATM, new Lucid ATM).
  • 20-F (filed Apr 30, 2026) showed shareholders' equity of -$72M and total debt of $132M as of Dec 31, 2025.
  • Up to 50 million ADSs authorized under Lucid agreement, each representing 20 ordinary shares (up to 1 billion ordinary shares).
  • Lucid receives 3.0% commission on gross sales. Proceeds intended for working capital.

Financial Impact

Up to $4.35M in additional equity issuance, representing ~31% dilution relative to current $14M market cap if fully drawn. Compounds dilution from existing convertible notes (April 2026 conversion agreements) and the $72M negative equity base.

dilutionshare countequity

Risk Factors

  • Up to 31% dilution from max drawdown of this ATM facility.
  • Nasdaq minimum bid price / MVPHS delisting risk — delisting could trigger debt acceleration or conversion penalties.
  • Further dilution from existing Yorkville SEPA and convertible note conversions.
  • Negative equity base (-$72M) signals balance sheet distress; cumulative warrants/convertible overhang may limit any rally.
  • Thinly traded $14M market cap makes price discovery volatile — ATM sales can push prices lower.

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001554855-26-001322
Exhibit: ex51_2.htm0001554855-26-001322
Document: MainDocument.htm0001554855-26-001322
Document: 0001554855-26-001322-index-headers.html0001554855-26-001322
Document: 0001554855-26-001322-index.html0001554855-26-001322
Document: 0001554855-26-001322.txt0001554855-26-001322
8 reports for TRIB
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +20.00%Feb 25, 2026
Filters
Rows
Reports for TRIB — sortable, filterable
Type Now
Jun 12, 2026
2d ago
6-K
BEARISH ★ 6/10
$0.6600 awaiting T+1awaiting T+1$0.6500 (+1.52%)
Jun 12, 2026
2d ago
424B5
BEARISH ★ 6/10
$0.6600 awaiting T+1awaiting T+1$0.6500 (+1.52%)
Jun 11, 2026
4d ago
EFFECT
BEARISH ★ 6/10
$0.6837 awaiting T+1awaiting T+1$0.6500 (+4.93%)
Jun 3, 2026
11d ago
F-1/A
BEARISH ★ 6/10
$0.6800 $0.6700▲ +1.47%▼ −1.13%$0.6500 (+4.41%)
May 26, 2026
20d ago
EFFECT
BEARISH ★ 6/10
$0.6500 $0.6800▼ −4.62%▼ −4.60%$0.6500 (+0.00%)
Mar 23, 2026
11w ago
Press Release
BULLISH ★ 7/10
$0.6000 $0.6100▲ +1.67%▲ +2.02%$0.6500 (+8.33%)
Mar 4, 2026
14w ago
EFFECT
NEUTRAL ★ 5/10
$0.7000 $0.7300▲ +4.29%▲ +4.86%$0.6500 (−7.14%)
Feb 25, 2026
15w ago
F-1
BEARISH ★ 8/10
$0.7500 $0.7200▲ +4.00%▲ +3.45%$0.6500 (+13.33%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 1h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access